Patients Why “rare disease” is a regulatory label, not a patient real... Regulators define a rare disease by how many people have it, and the answer depends on who is counting.
R&D Sponsored Decentralisation by design: Bringing the trial closer withou... In the third episode of the IQVIA-sponsored PSCS leadership video series, Sinead Callinan, Head of Patient Centred Delivery, discusses DCTs.
Digital Integration: The key to scalable decentralised trials Successful DCTs depend less on the technology deployed and more on how effectively those capabilities are integrated and executed.
Patients Putting patients first: 5 strategic shifts making clinical t... From gamified digital platforms to remote sample collection and agile site activation, sponsors are reimagining trial design.
News US govt taps Walgreens for decentralised trials Retail pharmacy giant Walgreens has signed a five-year contract with the US government – worth up to $100 million – for access to its decentralised clinical trials (DCT) network.
Patients FDA wants to make the home a healthcare hub During the pandemic, the world became accustomed to carrying out more activities from the home, including healthcare needs.
News Isomorphic Labs raises $5bn in massive third round In yet another sign of the appetite for AI companies among investors, Isomorphic Labs has raised a whopping $5bn in a Series C financing.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.